Answers are grounded in this paper and cite their sources.
Analysis shows Black individuals face higher risks of major bleeding compared to White individuals, suggesting a need for improved risk assessment models.
Guidelines recommend extended anticoagulation after a first unprovoked venous thromboembolism (VTE) among individuals at low risk of bleeding. However, racial disparities in bleeding risks during extended treatment remain understudied. To compare risks of anticoagulant-associated bleeding and performance of a risk assessment model (RAM) by racial groups during extended VTE treatment. We analyzed two prospective cohorts (223 Black participants and 4,314 White participants) with a first unprovoked/weakly provoked VTE who continued anticoagulation after ≥3 months of initial treatment. Primary outcome was adjudicated International Society of Thrombosis and Haemostasis-defined major bleeding. Secondary outcomes included intracranial hemorrhage (ICH), fatal bleeding, and clinically relevant non-major bleeding (CRNMB). We determined incidence and hazard ratios (HRs) by race, then adjusted for bleeding risk factors that included the CHAP (Creatinine, Hemoglobin, Age, antiPlatelet) model. Black participants had higher prevalence of bleeding risk factors and a 1.9-fold higher risk of major bleeding (HR 1.87, 95% CI 1.04-3.36) compared to White participants. Adjustment attenuated racial difference for major bleeding but not ICH (adjusted HR 2.35, 95% CI 1.23-4.48). Among those classified as low-risk by CHAP, Black participants had numerically higher major bleeding incidence than White participants (2.5 vs. 1.1 per 100 person-years). We did not observe racial disparities in fatal bleeding or CRNMBs. Black individuals on extended anticoagulation have higher risk of major bleeding compared to White individuals. This effect appears to persist among those classified as low-risk for bleeding. RAMs for anticoagulant-associated bleeding that are generalizable to racialized populations are needed.
No takes yet. Share an insight, caveat, or question.
Omar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: